Successful transcatheter aortic valve implantation in a Hodgkin lymphoma patient with severe aortic stenosis.
Transcatheter aortic valve implantation (TAVI) has emerged as an acceptable treatment modality for patients with severe aortic stenosis (AS) who are deemed unsuitable for conventional surgical aortic valve replacement. TAVI not only provides the treatment of AS, but also makes some other diseases treatable by relieving hemodynamic distress resulting from AS. In this case report, we presented a 74-year-old patient with Hodgkin's lymphoma (HL) that had been left untreated due to the development of acute pulmonary edema caused by severe degenerative AS during chemotherapy. This is the first report of the use of TAVI in a patient with HL.
Department of Cardiology, Atatürk Research and Training Hospital, Ankara, Turkey, cengaver61@yahoo.com.
Cenk
C
Sari
Tahir
T
Durmaz
Abdullah Nabi
AN
Aslan
Telat
T
Keleş
Murat
M
Akçay
Nihal
N
Akar Bayram
Hüseyin
H
Ayhan
Emine
E
Bilen
Serdal
S
Baştuğ
Haci Ahmet
HA
Kasapkara
Mehmet Burak
MB
Özen
Ömer Faruk
ÖF
Çiçek
Engin
E
Bozkurt
D000368:Aged; D001024:Aortic Valve Stenosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D004452:Echocardiography; D005260:Female; D006689:Hodgkin Disease / Q000150:complications*; D006801:Humans; D065467:Transcatheter Aortic Valve Replacement; D016896:Treatment Outcome